Skip to content
HeyJared

See Full Bio

Reporter

Indexed articles, last 90 days
15
Latest publication
Oct 1, 2026
Outlet visibility, for The Bull - Independent analysis and news on the global stock markets.
Top 5M sites
Earliest in this view
Sep 15, 2026

Latest articles

  1. Article · Oct 1, 2026 · See Full Bio

    Deep Yellow Shares Close At 52-Week Low: The Latest Look - The Bull (opens the original)

    Excerpt · Critical tone · English

    Read excerpt

    Deep Yellow shares (ASX: DYL) have started October on the back foot, closing the first session of the month at a fresh 52-week low as selling pressure continues to drag the stock lower. The DYL share price settled at A$1.13, a decline of 3.42% for the session and a level not seen in over twelve months. The stock has now shed 42.05% since the start of the year, a pullback that has pushed its RSI to 29.47, into oversold territory. The most recent news behind the latest leg lower came early this we

  2. Article · Oct 1, 2026 · See Full Bio

    Russell 2000 Surrenders Outperformance To The Nasdaq: The Latest - The Bull (opens the original)

    Excerpt · English

    Read excerpt

    The Russell 2000 small-cap index had started the year outperforming many of it’s bluechip peers, yet with the index now 8.85% down from its mid August high, there is a widening fault line across US markets. Treasury yields at 25 year highs, AI-driven capital concentration, and a renewed preference for quality balance sheets have pulled capital away from domestic companies, with tech now the outperformer. After touching a year-to-date high of 3,069.71 on August 14, the Russell 2000 has declined 8

  3. Article · Oct 1, 2026 · See Full Bio

    Cochlear Shares Pull Back After Months of Rebuilding, As Resistance Shapes Up - The Bull (opens the original)

    Excerpt · Critical tone · English

    Read excerpt

    Cochlear shares (ASX: COH) have fallen 6.63% to begin the month at A$130.34, with the stock coming under pressure at the end of a previously strong quarter. Whilst the Cochlear share price ended Q3 with a gain of 14.65%, resistance had been found three times over the past couple of months at A$145, a level that once again preceded this latest move lower. The stock remains down 50% since the start of 2026, and perhaps more concerning to near term momentum for technical traders, the price fell bel

  4. Article · Sep 30, 2026 · See Full Bio

    Real Estate Stocks Catch A Bid, Waking Up As September Ends - The Bull (opens the original)

    Excerpt · English

    Read excerpt

    The S&P/ASX 200 Real Estate Index climbed 3.68% to close out September, its best session since April 8, when the sector gained 3.9% following the initial US-Iran ceasefire agreement. The rally was broad across the sector, sweeping up developers, fund managers, and property platforms alike, though it was not enough to rescue the sector from a difficult month. The index still finished September 2.03% lower and remains deeply underwater for the year, sitting 16.16% below where it started 2026. Lend

  5. Article · Sep 29, 2026 · See Full Bio

    Maas Group Shares Hit New High as Bulls Target A$7 Hold - The Bull (opens the original)

    Excerpt · English

    Read excerpt

    Maas Group shares (ASX: MGH) briefly set a new all-time high of A$7.14 on Tuesday before pulling back below the closely watched A$7 psychological level, as markets continue to work through the bold pivot into AI and electrical infrastructure. The impressive September run in the MGH share price has positioned the stock among the ASX’s top performers for the month, bringing plenty of eyes to the name. MGH closed Tuesday’s session at A$6.93, up 0.87% on the day, though the inability to hold above A

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 5M sites

For The Bull - Independent analysis and news on the global stock markets., the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about See Full Bio